Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5
Open Access
- 24 August 2023
- journal article
- research article
- Published by Springer Nature in Bone Research
- Vol. 11 (1) , 1-12
Abstract
Proper regulation of Wnt signaling is critical for normal bone development and homeostasis. Mutations in several Wnt signaling components, which increase the activity of the pathway in the skeleton, cause high bone mass in human subjects and mouse models. Increased bone mass is often accompanied by severe headaches from increased intracranial pressure, which can lead to fatality and loss of vision or hearing due to the entrapment of cranial nerves. In addition, progressive forehead bossing and mandibular overgrowth occur in almost all subjects. Treatments that would provide symptomatic relief in these subjects are limited. Porcupine-mediated palmitoylation is necessary for Wnt secretion and binding to the frizzled receptor. Chemical inhibition of porcupine is a highly selective method of Wnt signaling inhibition. We treated three different mouse models of high bone mass caused by aberrant Wnt signaling, including homozygosity for loss-of-function inSost, which models sclerosteosis, and two strains of mice carrying different point mutations inLrp5(equivalent to human G171V and A214V), at 3 months of age with porcupine inhibitors for 5–6 weeks. Treatment significantly reduced both trabecular and cortical bone mass in all three models. This demonstrates that porcupine inhibition is potentially therapeutic for symptomatic relief in subjects who suffer from these disorders and further establishes that the continued production of Wnts is necessary for sustaining high bone mass in these models.Keywords
All Related Versions
This publication has 60 references indexed in Scilit:
- Cranial Reconstruction for Treatment of Intracranial Hypertension from Sclerosteosis: Case-Based UpdateWorld Neurosurgery, 2014
- Gpr177, a novel locus for bone mineral density and osteoporosis, regulates osteogenesis and chondrogenesis in skeletal developmentJournal of Bone and Mineral Research, 2012
- Wntless functions in mature osteoblasts to regulate bone massProceedings of the National Academy of Sciences, 2012
- Lrp5 functions in bone to regulate bone massNature Medicine, 2011
- Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient miceJournal of Bone and Mineral Research, 2010
- Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt SecretionDevelopmental Cell, 2006
- Essential Role of β-Catenin in Postnatal Bone AcquisitionJournal of Biological Chemistry, 2005
- Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast DifferentiationDevelopmental Cell, 2005
- A 52‐kb deletion in the SOST‐MEOX1 intergenic region on 17q12‐q21 is associated with van Buchem disease in the Dutch populationAmerican Journal of Medical Genetics, 2002
- Sclerosteosis — An autosomal recessive disorderClinical Genetics, 1977